Related Experiment Videos
Preventing recurrent depression using cognitive therapy with and without a continuation phase: a randomized clinical
R B Jarrett1, D Kraft, J Doyle
1The University of Texas Southwestern Medical Center, Department of Psychiatry, 5323 Harry Hines Blvd, Dallas, TX 75390-9149, USA.
Archives of General Psychiatry
|April 25, 2001
Summary
Continuation-phase cognitive therapy (C-CT) significantly reduces depressive relapse and recurrence in high-risk patients with recurrent major depressive disorder (MDD). Early onset and unstable remission indicate a greater need for C-CT.
Area of Science:
- Psychiatry
- Clinical Psychology
- Neuroscience
Background:
- Cognitive therapy (CT) skills may prevent depressive relapse, but effectiveness varies.
- Factors influencing CT's preventive impact remain unclear.
- Continuation-phase CT (C-CT) was developed to enhance skill retention and prevent relapse in vulnerable patients.
Purpose of the Study:
- To compare the efficacy of acute-phase CT (A-CT) with and without a continuation phase (C-CT) in preventing relapse.
- To identify patient characteristics that predict the need for C-CT.
- To evaluate the long-term durability of C-CT effects in recurrent major depressive disorder (MDD).
Main Methods:
- A randomized trial involving 156 patients with recurrent MDD.
- Participants received 20 sessions of A-CT.
- 84 unmedicated responders were randomized to 8 months of C-CT or a control group (evaluation only).
- Relapse and recurrence were assessed by a blinded clinician over 24 months.
Main Results:
- C-CT significantly reduced relapse rates compared to control during the 8-month continuation phase (10% vs. 31%).
- Over 24 months, C-CT demonstrated significant reductions in relapse and recurrence for patients with early-onset MDD (16% vs. 67%) and unstable remission (37% vs. 62%).
- Age of onset and quality of remission interacted with treatment assignment to influence long-term outcomes.
Conclusions:
- Eight months of C-CT is effective in reducing relapse and recurrence in high-risk patients with recurrent MDD.
- Specific risk factors, such as early onset and unstable remission, highlight the necessity for C-CT.
- C-CT offers a valuable strategy for maintaining remission in vulnerable populations.